1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Hormone Refractory Prostatic Cancer: new trials by email Literature Review of Hormone Refractory Prostatic Cancer trials Research Report on Hormone Refractory Prostatic Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer lorigerlimab, docetaxel, Prednisone - Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Neoplasms | Phase 2 | Completed | MacroGenics | 154 | 2023-09-28 | 2026-05-22 |
| A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors vobramitamab duocarmazine 2.0 mg (Arm A), vobramitamab duocarmazine 2.7 mg (Arm B), vobramitamab duocarmazine - Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer | Phase 2 | Terminated | MacroGenics | 192 | 2023-06-13 | 2026-02-09 |
Prostatic Neoplasms, Castration-Resistant (2) · Anus Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Small Cell (1) · Melanoma (1) · Small Cell Lung Carcinoma (1) · Squamous Cell Carcinoma of Head and Neck (1)
Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Prostatic Diseases (2) · Prostatic Neoplasms (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Anus Diseases (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Squamous Cell (1)
Docetaxel (1) · Prednisone (1) · abiraterone (1) · enzalutamide (1)
MacroGenics (2)
Australia (2) · Belgium (2) · France (2) · Poland (2) · Spain (2) · United Kingdom (2) · United States (2) · Bulgaria (1) · Georgia (1) · Italy (1) · Puerto Rico (1) · South Korea (1)
Liudmila Schafer, M.D. (1) · Pepi Pencheva, M.D. (1)